SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020853
Filing Date
2018-11-14
Accepted
2018-11-14 17:07:26
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20180930_10q.htm 10-Q 600649
2 EXHIBIT 31.1 ex_128764.htm EX-31.1 9223
3 EXHIBIT 31.2 ex_128766.htm EX-31.2 9222
4 EXHIBIT 32.1 ex_128765.htm EX-32.1 6321
  Complete submission text file 0001437749-18-020853.txt   3500610

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20180930.xml EX-101.INS 578983
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20180930.xsd EX-101.SCH 44616
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20180930_cal.xml EX-101.CAL 28751
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20180930_def.xml EX-101.DEF 332955
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20180930_lab.xml EX-101.LAB 257665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20180930_pre.xml EX-101.PRE 344363
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 181184997
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1